Monocacy Therapeutics Inc.

CIK 2137361 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Monocacy Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Aug 28, 2026D/A0002137361-26-000002
Aug 28, 2026D0002137361-26-000003
Aug 28, 2026D0002137361-26-000004
May 27, 2026D0002137361-26-000001